EXFO announces sale of Life Sciences and Industrial Division to The Riverside Company

EXFO Inc. (Nasdaq:EXFO) (TSX:EXF) announced today that it has sold its Life Sciences and Industrial Division to The Riverside Company, a global private equity firm, for US$24.3 million in cash. The purchase price is subject to adjustments for minimum working capital requirements.

The Life Sciences and Industrial Division, based in Toronto, Canada, provides solutions in medical device and opto-electronics assembly, fluorescence microscopy and other life science sectors. It generated US$25.4 million in sales and US$4.3 million in earnings from operations for the fiscal year ended August 31, 2010.

The Life Sciences and Industrial Division will be presented as a discontinued operation in EXFO's fiscal 2010 fourth-quarter and year-end financial results, which will be released after the close of markets on October 12, 2010.

"The creation of the Life Sciences and Industrial Division has served EXFO well over the years with steady sales and earnings, while providing an environment for this division's staff and management to perform," said Germain Lamonde, EXFO's Chairman, President and CEO. "The divestiture of this business will enable EXFO to concentrate all its efforts and resources on its core telecom test and service assurance business, while allowing the Life Sciences and Industrial Division to be more strategically developed. EXFO's exclusive focus on the global telecom industry will benefit customers, employees and shareholders in the long term."

Source EXFO Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.